These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23828830)

  • 1. Transcoronary septal ablation in hypertrophic obstructive cardiomyopathy by embolizing microspheres.
    Dickmann B; Baars T; Heusch G; Erbel R
    Eur Heart J; 2013 Aug; 34(31):2489. PubMed ID: 23828830
    [No Abstract]   [Full Text] [Related]  

  • 2. Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy.
    Agarwal S; Puri S; Wang H
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):350-4. PubMed ID: 23992655
    [No Abstract]   [Full Text] [Related]  

  • 3. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Ben-Dor I; Maluenda G; Wang Z; Lindsay J; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2012; 13(1):72-4. PubMed ID: 21296034
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying the target septal perforator prior to alcohol septal ablation in hypertrophic obstructive cardiomyopathy: a new application for computed tomography coronary angiography.
    Spratt JC; Langrish JP
    Heart; 2011 Oct; 97(20):1718-9. PubMed ID: 21807658
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block.
    Veselka J; Krejčí J; Tomašov P; Durdil V; Riedlbauchová L; Honěk J; Honěk T; Zemánek D
    Int J Cardiol; 2014 Feb; 171(2):e37-8. PubMed ID: 24360153
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy.
    Jiang TY; Wu XS; Lu Q; Meng X; Jia CQ; Zhang Y
    Chin Med J (Engl); 2004 Feb; 117(2):296-8. PubMed ID: 14975219
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of hypertrophic obstructive cardiomyopathy complicated by a single coronary artery treated by transcoronary septal ablation.
    Hara H; Ishii K; Nakamura M
    J Invasive Cardiol; 2006 May; 18(5):234-8. PubMed ID: 16670451
    [No Abstract]   [Full Text] [Related]  

  • 8. Invasive thoughts: honoring two decades of alcohol septal ablation for hypertrophic cardiomyopathy.
    Naidu SS
    J Invasive Cardiol; 2013 Aug; 25(8):369-70. PubMed ID: 23913599
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Binder J; Nishimura RA; Holmes DR; Rihal CS; Gersh BJ; Bresnahan JF; Ommen SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E58-67. PubMed ID: 22511295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
    Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol septal ablation in hypertrophic cardiomyopathy: an opportunity to be taken.
    Gimeno JR; Tomé MT; McKenna WJ
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):314-8. PubMed ID: 22381943
    [No Abstract]   [Full Text] [Related]  

  • 12. Substitution of ethanol with specially designed microspheres in a TASH procedure.
    Latsios G; Gerckens U; Mueller R; Grube E
    EuroIntervention; 2011 Feb; 6(7):889-92. PubMed ID: 21252025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve perforation following transcoronary ablation of septal hypertrophy.
    Galeone A; Barreda E; Choussat R; Leprince P; Pavie A
    Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):595-6. PubMed ID: 23087309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Moya Mur JL; Salido Tahoces L; Mestre Barcelo JL; Fernandez Golfín C; Zamorano Gómez JL
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):226. PubMed ID: 23988326
    [No Abstract]   [Full Text] [Related]  

  • 15. Low alcohol tolerance--a blessing for septal ablation.
    Kimmelstiel C; Kapur NK
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):108-9. PubMed ID: 24975263
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient.
    Höblinger A; Tiemann K; Nickenig G; Sauerbruch T; Lammert F
    Z Gastroenterol; 2008 Oct; 46(10):1194-7. PubMed ID: 18937189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you.
    Nishimura RA; Ommen SR
    Circ Cardiovasc Interv; 2010 Apr; 3(2):91-3. PubMed ID: 20407109
    [No Abstract]   [Full Text] [Related]  

  • 18. Obstruction in hypertrophic cardiomyopathy: how often does it occur? Should it be treated? If so, how?
    Braunwald E
    Circulation; 2012 Nov; 126(20):2369-70. PubMed ID: 23076969
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of atrial pacing during alcohol septal ablation.
    Buergler JM; Nagueh SF
    J Invasive Cardiol; 2010 Mar; 22(3):146-7. PubMed ID: 20197584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.